Toggle Summary |
Onconova Therapeutics, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Reports Second Quarter 2014 Financial and Operational Results
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2014 Financial Results and Conference Call
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Reports First Quarter 2014 Financial and Operational Results
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Announces Timing for First Quarter 2014 Financial Results and Conference Call
|
View HTML
|
Toggle Summary |
Onconova Development Programs Highlighted in Seven Presentations at AACR Annual Meeting
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Reports Fourth Quarter and Year-End 2013 Financial Results and Outlines Key Objectives for 2014
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. Announces Timing for Fourth Quarter and Year-End 2013 Financial Results and Conference Call
|
View HTML
|
Toggle Summary |
Onconova Therapeutics, Inc. to Present at the Cowen and Company 34th Annual Health Care Conference
|
View HTML
|
Toggle Summary |
Onconova Announces Results From Phase 3 ONTIME Trial of Rigosertib in Higher Risk Myelodysplastic Syndromes (MDS)
|
View HTML
|